-
11-08-2020, 01:55 PM
#18151
Member
Originally Posted by clip
Must be direct broking? I can't see this from ASB either
It shows on snow leopard's link
-
11-08-2020, 01:58 PM
#18152
Member
Originally Posted by Snow Leopard
Great, thanks. Has anyone been able to reconcile the $US40m reimbursement figure for unpaid tests PEB is chasing from CMS? My calculations work out at $16.7m USD ~$26.1m NZD (22,000 tests @ $760 USD)
-
11-08-2020, 02:09 PM
#18153
Member
Originally Posted by baaantom
Great, thanks. Has anyone been able to reconcile the $US40m reimbursement figure for unpaid tests PEB is chasing from CMS? My calculations work out at $16.7m USD ~$26.1m NZD (22,000 tests @ $760 USD)
Perhaps charged out at full price per test before a signed contract gave a significant discount per test?
-
11-08-2020, 02:38 PM
#18154
Member
Originally Posted by baaantom
Great, thanks. Has anyone been able to reconcile the $US40m reimbursement figure for unpaid tests PEB is chasing from CMS? My calculations work out at $16.7m USD ~$26.1m NZD (22,000 tests @ $760 USD)
And always the distinct possibility that CMS will say No. They were running the tests in parallel to their usual tests in trials so would be effectively paying for testing twice.
Negotiations will be taking place on this one.
Don't count the dollar coins until/if they appear.
-
11-08-2020, 02:42 PM
#18155
I do not understand why PEB would be reimbursed for previous tests and PEB are saying that it could be anywhere between 0$ and many millions. Can anybody explain to me what leverage PEB have to get the payment. CMS are not going to pay because they want to be nice guys.
-
11-08-2020, 02:47 PM
#18156
Future price would be one thing to leverage off. At the end of the day they can always continue to pay for the more costly test option too... But the minnow is never in a strong position...
-
11-08-2020, 03:01 PM
#18157
Originally Posted by t.rexjr
Future price would be one thing to leverage off. At the end of the day they can always continue to pay for the more costly test option too... But the minnow is never in a strong position...
Good point - essentially discounting future tests To get some money up front.
-
11-08-2020, 03:41 PM
#18158
Member
Originally Posted by baaantom
Great, thanks. Has anyone been able to reconcile the $US40m reimbursement figure for unpaid tests PEB is chasing from CMS? My calculations work out at $16.7m USD ~$26.1m NZD (22,000 tests @ $760 USD)
I very much doubt that ALL Doctors in the User Trials were running parallel tests up to 30th June before switching over. Some would have switched months ago so it would be fair to get some reimbursement.
Whether life is fair is, of course, another story.
The negotiators will be busy negotiating with this and other tools in their toolbox so we just have to wait and see. It seems they have started with Best Case and hope to settle... somewhere...
There were up to 309 people at the Virtual AGM (if that fluctuating number at the top of the screen next to the word "LIVE" was people)
Of the others who were "there" any other thoughts?
-
11-08-2020, 03:45 PM
#18159
Originally Posted by t.rexjr
Future price would be one thing to leverage off. At the end of the day they can always continue to pay for the more costly test option too... But the minnow is never in a strong position...
That is the way I see it too, also I observe David Darling the CEO has his specialisation in science not business deals.
-
11-08-2020, 03:55 PM
#18160
Originally Posted by Merc
And always the distinct possibility that CMS will say No. They were running the tests in parallel to their usual tests in trials so would be effectively paying for testing twice.
Negotiations will be taking place on this one.
Don't count the dollar coins until/if they appear.
Given the rate of knots that the US counterfeits its currency (& the current debasement of it!!) - as well as the inordinate amount of time that has passed since test number 1 ... PEB has every reason to expect the full price of all the back tests.
In fact, IMO, given the above (& the immense benefit/s CXBladder offers) - if the US negotiated for a deep discount on those back tests ... it would be tantamount to theft!
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks